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Abstract 
Cell adhesion to substratum and activation of tyrosine kinases are essential for the progression of cell cycle through G1 phase in 
mammalian cells. The kinetic studies of mouse BALB/c 3T3 fibroblasts howed that serum was no longer equired for the progression of 
G1/S phase transition. In contrast, cell adhesion was essentially required in late G1 phase, especially at the period of G1/S transition. 
Among the kinase inhibitors used to elucidate the signal transduction caused by cell adhesion, tyrosine kinase inhibitors, genistein and 
herbimycin A, blocked the G1/S transition most effectively when cells were exposed to the inhibitors at the period of G1/S transition. 
Cell adhesion was not critically required for cells to undergo DNA synthesis once they had passed the G1/S boundary, and the effects of 
tyrosine kinase inhibitors on the progression of S phase were also not critical. The expressions of histone H2B and dihydrofolate 
reductase (DHFR) genes (S phase specific genes) and also the transcription factor E2F-I gene (an activator of DHFR gene) were 
suppressed when cells were cultured without adhesion or exposed to the tyrosine kinase inhibitors. These results uggest that cell adhesion 
to substratum plays an important role in the G1/S phase transition of mouse BALB/c 3T3 fibroblasts through the activation of tyrosine 
kinases other than growth factor eceptor-tyrosine kinases. 
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1. Introduction 
Both growth factors in serum and cell adhesion to 
extracellular substratum are the essential factors for the 
proliferation of fibroblasts in culture. Growth factors are 
required in facilitating the fibroblast cell cycle through G 1 
phase up to the restriction point located in late G1 phase 
[1-3]. Once cells have passed the restriction point, growth 
factors are no longer required for cells to go through the 
remaining G1, S, G2, and M phases [1-4]. Intracellular 
protein tyrosine kinases are important for cell cycle pro- 
gression, specifically for growth factor-mediated signal 
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transduction. The activation of growth factor receptor- 
tyrosine kinases is an initial step in the action of growth 
factors. The receptor tyrosine kinases autophosphorylate 
the receptors, which triggers the interaction of Grb2, mSos, 
and ras proteins through their SH2/3 domains, followed 
by activation of raf-l, MAP kinase kinase, and MAP 
kinase [5,6]. And it is also reported that src family protein 
tyrosine kinases are required for some growth factors to 
transmit mitogenic responses in their association with 
growth factor-mediated signal transduction pathways [7]. 
The requirement of cell adhesion for the growth of 
non-transformed cells in culture has been known as an- 
chorage dependency for normal cell proliferation [8,9]. 
Fibroblasts in suspension culture can go through S, G2, 
and M phases, but they cannot enter into S phase from G1 
[4,8]. Recently it has been reported that cell adhesion is 
required specifically for the G1/S  transition of fibroblast 
cell cycle by affecting the cyclin A expression [10,11]. It is 
also suggested that tyrosine kinases play an important role 
in integrin-mediated signal transduction. Integrins located 
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in focal adhesion plaques interact with extracellular matri- 
ces, followed by the activation of focal adhesion kinase 
(pp125 FAK, FadK) by the phosphorylation f its tyrosine 
residues [12,13]. The tyrosine-phosphorylated FAK binds 
Grb2 and mSos through their SH2/3 domains and leads to 
the activation of MAP kinase [14]. Src family tyrosine 
kinases can also phosphorylate FAK on its tyrosine 
residues, and associate with FAK through their SH2 do- 
mains [13,15]. Nevertheless, there is no evidence as to 
whether integrin-mediated activation of tyrosine kinases is 
essential for the G1/S phase transition or not. 
Given these circumstances, we investigated the require- 
ments for cell adhesion and activation of tyrosine kinases 
in GI phase for the G1/S phase transition by kinetic 
studies. Our results suggest hat cell adhesion is required 
for the G1/S phase transition through activating tyrosine 
kinases other than growth factor receptor-tyrosine kinases. 
And we discuss the possible regulatory mechanisms of cell 
adhesion and tyrosine kinase activation on the S phase 
entry. 
2. Materials and methods 
2.1. Materials 
Poly(HEMA) was purchased from Aldrich Chemical 
Co. (Milwaukee, WI). Genistein, daidzein, herbimycin A, 
1-(5-Isoquinolinylsulfonyl)-2-methylpiperazine (H-7), and 
N-(6-aminoethyl)-5-chloro- 1-naphthalenesulfonamide (A- 
3) were purchased from Funakoshi Chemical Co. (Tokyo, 
Japan). Aphidicolin was from Wako Pure Chemical Indus- 
tries (Osaka, Japan). [6- 3H]Thymidine, [ a- 32 P]dCTP, and 
NCS tissue solubilizer were from Amersham Japan (Tokyo, 
Japan). The random primer DNA labeling kit was from 
Takara Shuzo Co. (Kyoto, Japan). H-7 and A-3 were 
dissolved in distilled water, and genistein, daidzein, and 
herbimycin A were dissolved in DMSO. 
2.2. Cell culture 
Mouse BALB/c 3T3 fibroblast cells (clone A31) were 
obtained from the Japanese Cancer Research Resources 
Bank. New cultures were started from the frozen stock 
once each month to avoid the use of phenotypically changed 
cells. Cells were cultured with DME/FI2 medium supple- 
mented with 200 units/ml penicillin G, 0.1 mg/ml 
streptomycin sulfate, and 10% FCS and incubated at 37°C 
in a humidified atmosphere of 5% CO 2. To synchronize 
the cells to quiescent state, cells (1 × 105 cells in a 60-mm 
culture dish or 3 X 105 cells in a 90-mm culture dish) were 
cultured for 4-24 h in the medium containing 10% FCS 
after plating, and then medium was changed to a medium 
containing 0.3-0.4% FCS, followed by culture for 72 h. 
To advance cell cycle from quiescent to S phase, quiescent 
cells were stimulated with 10-15% FCS (10% and 15% 
FCS showed the same effect for promoting the cell growth). 
To culture the cells without adhesion, monolayer cells 
were detached by trypsinization (0.125% trypsin/0.02% 
EDTA for 3-5 rain at 37°C) and then cultured on plastic 
dishes entirely coated with poly(HEMA) [4,9]. To prepare 
the poly(HEMA)-coated ishes, poly(HEMA) was dis- 
solved with 85% ethanol and 15% 1 M Tris-HCl (pH 7.5), 
and the solution was poured onto plastic culture dishes 
(poly(HEMA) 2 mg/60-mm dish or 5 mg/90-mm dish). 
The dishes were evenly coated with poly(HEMA) in the 
oven with occasional agitation and sterilized by ultraviolet 
exposure. The coated dishes were rinsed once with PBS 
before use. The cells cultured in the poly(HEMA)-coated 
dishes were incapable of forming adhesion plaques and 
stayed in a round form. The poly(HEMA) itself showed no 
cytotoxic or cytostatic effects under our experimental con- 
ditions so far examined (data not shown). To deprive the 
serum of the culture medium, the medium containing 10% 
FCS was changed to the medium containing 0.3-0.4% 
FCS previously used for preparing quiescent cells. To 
synchronize the cells at G1/S boundary, aphidicolin (an 
inhibitor for DNA polymerase-ce) was added to the culture 
medium (5 /zg/ml) at 7 h after 10% serum stimulation of 
quiescent cells and cultured for an additional 17 h [4]. 
Then, aphidicolin was removed (the medium was changed 
to the medium containing 10% FCS without aphidicolin) 
to synchronously start S phase. When cells were treated 
with genistein, daidzein, and herbimycin A, the cells in the 
control dishes were treated with the same amount of 
DMSO as that in the reagents. Viable cell numbers were 
counted by the 0.15% trypan blue exclusion method with 
the use of a hemocytometer. 
2.3. DNA synthesis 
The level of DNA synthesis was measured by [6- 
3H]thymidine incorporation i to acid-insoluble materials. 
Cells were cultured with the medium containing [6- 
3H]thymidine (0.5 /~Ci/ml, 0.33 Ci/mmol) and 2 /zM of 
cc, ld thymidine for indicated urations. The difference of 
specific activity of thymidine between the medium con- 
taining 10% serum and serum-free medium was negligible. 
When cells were harvested, viable cell number in the small 
aliquot was counted after trypsinization, and the cells in 
another aliquot were fixed with 7% trichloroacetic acid. 
The acid-insoluble materials were collected on glass filters. 
The filters were incubated with NCS tissue solubilizer at 
50°C for 16 h, and the radioactivities in the filters were 
counted with a liquid scintillation counter (Packard Tri- 
Carb 4530). 
2.4. Northern blot analysis 
The isolation of total cellular RNAs and Northern blot 
analysis were performed according to the method de- 
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scribed by Sambrook et al. [16]. Monolayer cultured cells 
were washed twice with ice-cold PBS and harvested with 
ice-cold 10 mM EDTA (pH 8.0), 0.5% SDS, followed by 
the addition of ice-cold 0.1 M sodium acetate (pH 5.2), 10 
mM EDTA (pH 8.0). Then RNAs were extracted with 
water-saturated phenol. The cells cultured in 
poly(HEMA)-coated ishes were collected by low-speed 
centrifugation at4°C, washed once with ice-cold PBS, and 
then harvested with the same procedures described above. 
Extracted RNAs were precipitated with ethanol and quanti- 
tated by spectrophotometer. Each 7 ~g of total cellular 
RNA was electrophoresed through 1% agarose gel contain- 
ing 6% formaldehyde. The RNA was completely trans- 
ferred to a nylon membrane filter by capillary action. The 
filter was hybridized with a 32 P-labeled DNA probe in a 
solution of 50% formamide, 5 X SSPE, 5 X Denhardts' 
solution, 0.1% SDS, and 20/zg/ml  herring sperm DNA at 
42°C for 16 h, followed by washing with 0.1 × SSC, 0.1% 
SDS at 50°C and then autoradiographed. DNA probes 
(spec. act. 1-2 x 109 cpm//zg DNA) were radiolabeled 
using the random primer DNA labeling kit with [a- 
32p]dCTP. DNA probes used are as follows: chicken his- 
tone H2B gene, pKRla-l.3. [17]; human DHFR pseudo-1 
gene, CHB201 [18]; mouse E2F-1 cDNA, pcDNA3-mE2F- 
1 [19]; rat GAPDH cDNA, pSPGAPDH [20]; and rat 
ribosomal protein L35a cDNA, pRL35a [21]. The DNA 
probes were sequentially hybridized to RNAs on the same 
filter after the removal of previously hybridized probes. 
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Fig. 1. Serum is required in early GI phase, and cell adhesion is required at the G I /S  phase transition. (A) Serum and cell adhesion are required for the 
progression of G1 phase. O, time course of DNA synthesis after serum stimulation. Quiescent BALB/c 3T3 cells in monolayer culture were stimulated 
with 15% FCS. [3H]Thymidine was added to the medium at the same time that 15% serum was introduced to the cultures. Cells were cultured in the 
medium containing 10% FCS and [3H]thymidine until each time point when DNA synthesis was measured. O, quiescent monolayer cells were detached 
by trypsinization and transferred topoly(HEMA)-coated dishes, and then stimulated with 15% FCS. D, quiescent monolayer cells were not stimulated with 
15% FCS. (B) Serum is required in early G1 phase and no longer required at the G I /S  transition. Quiescent cells were stimulated with 10% FCS. 
[3 H]Thymidine was added to the medium at the same time that 10% serum was introduced to the cultures. The medium was changed to the serum-deprived 
medium at each serum-deprivation time point. The cells were cultured in the serum-deprived medium containing [3H]thymidine. DNA synthesis was 
measured at 24 h point after serum stimulation. The level of DNA synthesis was plotted at each serum-deprivation time point. (C) Cell adhesion is required 
at the G1/S phase transition. Quiescent monolayer cells were stimulated with 10% FCS. [3H]Thymidine was added to the medium at the same time that 
10% serum was introduced to the cultures. Cells were detached by trypsinization at each detachment time point and then cultured without adhesion in 
poly(HEMA)-coated dishes in the medium containing 10% FCS and [3H]thymidine. DNA synthesis was measured at 24 h point after serum stimulation. 
The level of DNA synthesis was plotted at each detachment time point. (D) Trypsinization itself has no effect on DNA synthesis. The same procedures 
described in (C) were performed in this experiment, except hat cells were detached by trypsinization ateach time examined and immediately re-attached in 
ordinary culture dishes. All values in the graphs represent means, and T bars represent s andard eviations (n = 6-12). 
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3. Results 
3.1. Growth factors in serum are no longer required for 
the G1/S  phase transition 
Mouse BALB/c  3T3 fibroblast cells were synchronized 
to quiescent state (GO phase) by the culture in the medium 
containing 0.3-0.4% FCS for 72 h. When quiescent cells 
were stimulated with 10-15% FCS, it was necessary for 
growth factors in serum to act for growth promotion by 
activating the growth factor receptor-tyrosine kinases. The 
serum-stimulated cells advanced the cell cycle into S phase 
with a gap-period (G1 phase) for 12-14 h, and S phase 
continued for 9-10 h (Fig. 1A, O). The immunohisto- 
chemical staining for newly synthesized DNA showed that 
most cells entered into S phase synchronously (data not 
shown). According to the time course profile of DNA 
synthesis, the period of G1/S  phase transition approxi- 
mately corresponded to the period of 10-14 h after serum 
stimulation. If the quiescent cells were not stimulated by 
serum, cells could not go into S phase (Fig. 1A, []). To 
determine the period when growth factors exert their ef- 
fects on the cell cycle, we performed the kinetic experi- 
ment for serum action, in which experiment DNA synthe- 
sis was measured when cells were exposed to 10% serum 
for various durations after serum stimulation in the G1 and 
S phases (Fig. 1B). For example, the level of DNA synthe- 
sis of the cells which were exposed to serum for 0 -6  h 
after serum stimulation is shown at 6 h in the graph (the 
fourth plot from the left in Fig. 1B). The graph clearly 
shows that the cells demand serum for the progression into 
S phase for 0 -8  h (mostly 0 -4  h) after serum stimulation. 
The result indicates that growth factors in serum are 
required in early G1 phase and no longer required at the 
period of G 1/S  transition. 
3.2. Cell adhesion is required in late G1 phase, especially 
at the period of G1 / S transition 
The cells cultured without adhesion in poly(HEMA)- 
coated dishes could not go into S phase even though they 
were stimulated by serum (Fig. I A, • ) ,  which means that 
cell adhesion to substratum as well as serum is essential 
for the progression of G1 phase. To determine the period 
when cell adhesion is required for progression on the cell 
cycle, we performed a kinetic experiment to determine the 
requirement of cell adhesion in the G1 and S phases. The 
experiment was similar to that to determine the require- 
ment of serum. In this experiment, DNA synthesis was 
measured when cells were cultured with adhesion in ordi- 
nary culture dishes for various durations after serum stimu- 
lation in the G1 and S phases in the presence of 10% 
serum (Fig. 1C). For example, the level of DNA synthesis 
of the cells which were cultured with adhesion for 0 -8  h 
after serum stimulation is shown at 8 h in the graph (the 
third plot from the left in Fig. 1C). The result was much 
different from that in Fig. lB. Contrary to the fact that 
serum was no longer required at the G1/S  phase transi- 
tion, adhesion was certainly required in late G1 phase, 
especially at the period of G1/S  transition (for 8-14 h 
after serum stimulation). Since it seemed possible that 
trypsinization might have some artificial effects in this 
experiment, we performed a control experiment for Fig. 
1C in which the cells were re-attached to ordinary culture 
dishes immediately after the detachment by trypsinization 
(Fig. 1D). The result showed that the level of DNA 
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Fig. 2. Cell adhesion and tyrosine kinase inhibitors have no critical effect on S phase progression. BALB/c 3T3 cells were synchronized at G1/S 
boundary with aphidicolin, and then the aphidicolin was removed to start S phase. (A) Effect of cell adhesion. O, the cells cultured in monolayer in
ordinary culture dishes during S phase; O, the cells cultured without adhesion i poly(HEMA)-coated dishes during S phase. The synchronized cells were 
detached and transferred to poly(HEMA)-coated dishes filled with 10% FCS without aphidicolin. (B) Effect of genistein. O, the cells cultured in 
monolayer during S phase in a medium containing DMSO; O, the cells cultured in monolayer during S phase in a medium containing genistein (15 
/xg/ml). DMSO and genistein were added to the medium immediately after aphidicolin removal. (C) Effect of herbimycin A. 1, aphidicolin was not 
removed from the medium. 2-5, aphidicolin was removed and the following reagents were added: 2, DMSO; 3, genistein (15 /xg/ml); 4, daidzein (15 
/xg/ml); 5, herbimycin A (0.2 /xg/ml). [3H]Thymidine was added to the medium immediately after emoval of aphidicolin, and DNA synthesis was 
measured ateach time point examined (A, B) or at 9 h (C) after aphidicolin removal. All values in these graphs represent means, and T bars represent 
standard deviations (n = 6-8). 
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synthesis and cell cycle progression were not affected by 
the trypsinization procedure. 
Furthermore, we examined whether cell adhesion is 
required to facilitate the S phase progression (Fig. 2A). 
The cells were synchronously started from G1/S boundary 
through S phase by removal of aphidicolin from the cul- 
ture medium. When cells were cultured without adhesion 
during S phase, the level of DNA synthesis was suppressed 
to 75-80% of the levels of the control (samples 6 h and 9 
h in Fig. 2A; P < 0.05, compared to the level of the 
control; t-test). However, when cells were cultured without 
adhesion from 6 h after serum stimulation, the level of 
DNA synthesis was suppressed to 10% of the level of the 
control (Fig. 1C). Therefore, we concluded that cell adhe- 
sion in S phase was not critically required for undergoing 
DNA synthesis. These results indicate that cell adhesion 
plays an important role in late G1 phase, especially at the 
period of G 1/S transition. 
3.3. The protein tyrosine kinase inhibitors, genistein and 
herbimycin A, block the G1 ,/S phase transition 
To investigate the necessity of tyrosine kinases other 
than growth factor receptor-tyrosine kinases at the period 
of G 1/S transition, we examined the effects of the protein 
tyrosine kinase inhibitors, genistein and herbimycin A. The 
cells cultured with serum-free medium from 6 h after 
serum stimulation were treated with the inhibitors for 6-24 
h after serum stimulation (late G1 and S phases). The 
levels of DNA synthesis in the cells treated with the 
inhibitors were compared to those in control cells (Fig. 3). 
Genistein is a member of isoflavone and inhibits tyrosine 
kinase activity by competing for ATP [22]. Daidzein, 
which is structurally similar to genistein, but has no in- 
hibitory effect on tyrosine kinases, was used as a control. 
It was shown that DNA synthesis was suppressed by 
genistein in a dose-dependent manner, but not by daidzein 
(Fig. 3A) (samples 5, 6, and 7 in Fig. 3A; P<0.01,  
compared to the level of sample 3; t-test). The effective 
concentration of genistein was consistent with that of the 
reported one (half maximal dose for inhibition of tyrosine 
kinase activities = 6-8 /zg/ml). Herbimycin A, another 
tyrosine kinase inhibitor, is a benzoquinonoid ansamycin 
antibiotic and inhibits the activity of tyrosine kinases by its 
binding to the reactive SH groups essential for the activity 
[23]. Therefore, sulfhydryl compounds, such as /3-mer- 
captoethanol, are able to cancel the effect of herbimycin A. 
Again, it was shown that herbimycin A markedly sup- 
pressed DNA synthesis of the cells and its effect was 
cancelled by/3-mercaptoethanol (Fig. 3B) (samples 4, 5, 6, 
and 7 in Fig. 3B; P<0.01,  compared to the level of 
sample 3; t-test). By checking trypan blue exclusion activ- 
ity of the cells and the levels of ribosomal protein L35a 
and GAPDH gene expression (Fig. 5), we confirmed that 
genistein and herbimycin A had no cytotoxic effect at the 
concentrations u ed in this experiment. Furthermore, we 
examined the effects of two serine/threonine protein ki- 
nase inhibitors, H-7 and A-3, on DNA synthesis. H-7, an 
isoquinolinesulfonamide derivative, is a specific inhibitor 
of cAMP- and cGMP-dependent protein kinases and pro- 
tein kinase C and is effective at low concentrations (K i = 
3.0-6.0/zM) [24]. A-3, a naphthalene-sulfonamide deriva- 
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Fig. 3. Tyrosine kinase inhibitors block the G1/S phase transition. 
Quiescent cells were stimulated with 10% FCS, and then serum was 
removed at 6 h after serum stimulation. The cells were cultured until 24 h 
after serum stimulation in a serum-deprived medium. The reagents and 
[3H]thymidine were added to the serum-deprived medium immediately 
after serum deprivation (at 6 h). DNA synthesis was measured at 24 h 
after serum stimulation. (A) Effect of genistein. 1, quiescent cells (not 
stimulated with serum); 2, serum-stimulated cells with no reagents. 3-11, 
serum-stimulated cells administered with the following reagents: 3, 
DMSO; 4, genistein (2 /xg/ml); 5, genistein (5/xg/ml);  6, genistein (10 
/xg/ml); 7, genistein (15 /zg/ml); 8, daidzein (2 /xg/ml); 9, daidzein (5 
/xg/ml); 10, daidzein (10 /zg/ml); 11, daidzein (15 /zg/ml). (B) Effect 
of herbimycin A. l, quiescent cells (not stimulated with serum); 2, 
serum-stimulated cells with no reagents. 3-9, serum-stimulated cells 
administered with the following reagents: 3, DMSO; 4, herbimycin A 
(0.02 /xg/ml); 5, herbimycin A (0.05 /xg/ml); 6, herbimycin A (0.1 
/xg/ml); 7, herbimycin A (0.2 /xg/ml); 8, herbimycin A (0.1 /xg/ml)+ 
/3-mercaptoethanol (20 /zM); 9, herbimycin A (0.1 /xg/ml)+/3-mer- 
captoethanol (60/xM). (C) Effects of H-7 and A-3. 1, quiescent cells (not 
stimulated with serum); 2, serum-stimulated cells with no reagents. 3-8, 
serum-stimulated cells administered with the following reagents: 3, H-7 
(5 /xM); 4, H-7 (10 /xM); 5, H-7 (20 ~M); 6, A-3 (5 ~M); 7, A-3 (10 
/zM); 8, A-3 (20/xM). Shaded bars represent means, and T bars represent 
standard eviations (n = 6-12). 
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tive, also inhibits the activities of cAMP- and cGMP-de- 
pendent protein kinases, myosin light chain kinase, and 
casein kinase II at low concentrations (K~ = 3.8-7.4 p~M) 
[25]. The result showed that both H-7 and A-3 had no 
significant effect on DNA synthesis even though the con- 
centration used was as high as 20 /xM (Fig. 3C). 
The requirement of tyrosine kinases for S phase pro- 
gression was examined using the inhibitors in an experi- 
ment similar to that used to investigate the requirement of
cell adhesion for S phase progression (Fig. 2B). When the 
cells were treated with genistein (at 15 /~g/ml, which 
suppressed DNA synthesis to less than 5% of the control 
when used from 6 h after serum stimulation) during S 
phase, DNA synthesis was suppressed to 65-70% of the 
levels of the control (samples 9 h in Fig. 2B; P < 0.01, 
compared to the level of the control; t-test). Herbimycin A
(0.2 /~g/ml) inhibited DNA synthesis to the same extent 
as genistein, but daidzein had no effect (Fig. 2C) (samples 
3 and 5 in Fig. 2C; P < 0.01, compared to the level of 
sample 2; t-test). The result indicates that the effect of the 
tyrosine kinase inhibitors on S phase progression was 
much less than that on the G1/S  phase transition. There- 
fore, we concluded that tyrosine kinases other than growth 
factor receptor-tyrosine kinases were not critically required 
for S phase progression but were significantly required for 
cells to advance the G I /S  phase transition. 
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protein and GAPDH genes were examined as internal standards. (B) 
DHFR and E2F-1 gene xpressions. Conditions were the same as (A). (C) 
Histone H2B gene xpression. Conditions were the same as (A), except 
that serum was removed at10 h after serum stimulation a d the reagents 
were added immediately after serum deprivation. 
3.4. The expressions of  histone H2B, DHFR, and tran- 
scription .factor E2F-I genes were suppressed in the cells 
cultured without adhesion and also in the cells treated 
with the tyrosine kinase inhibitors 
To see the effects of cell adhesion and tyrosine kinase 
inhibitors on growth-related gene expression, we examined 
the expressions of histone H2B, DHFR, and transcription 
factor E2F-I genes in the cells cultured in poly(HEMA)- 
coated dishes and treated with the tyrosine kinase in- 
hibitors by Northern blot analysis. The mRNA levels of 
ribosomal protein L35a and GAPDH were also determined 
as internal standards. Histone H2B and DHFR genes were 
expressed in S phase (Fig. 4, S). Histone H2B and DHFR 
mRNAs hardly accumulated (only 7-10% of the level of 
Z Kuzumaki et al./Biochimica et Biophysica Acta 1310 (1996) 185-192 191 
the control by densitometric analysis) when cells were 
cultured without adhesion from 6 h after serum stimulation 
(late G1 and S phases) (Fig. 4A(-) ) .  In contrast, when 
cells were cultured without serum in the late G1 and S 
phases, both genes were expressed to more than 50-60% 
of the levels of the control (Fig. 4, S( - ) ) .  And also 
histone H2B and DHFR mRNAs did not accumulate when 
cells were treated with genistein and herbimycin A, while 
they accumulated when cells were treated with daidzein, 
H-7, and A-3 (Fig. 5A,B). Even though the cells were 
treated with the reagents from as late as 10 h after serum 
stimulation, genistein and herbimycin A significantly in- 
hibited the histone H2B gene expression (Fig. 5C). The 
result in Fig. 5C suggests that the tyrosine kinase inhibitors 
exert their effects most effectively when they are used at 
the period of G I /S  transition. 
E2F-I is known as an important transcription factor for 
the G I /S  transition, as it activates transcription of DHFR 
gene [26]. The E2F-1 gene was induced at 12 h after serum 
stimulation, and its expression was the highest at 18 h 
(Fig. 4, S). The expression of E2F-1 gene was completely 
inhibited when the cells were cultured without adhesion 
(Fig. 4, A( - ) ) .  In contrast, its expression was not signifi- 
cantly changed when the cells were cultured with serum- 
free medium (Fig. 4, S( - ) ) .  When cells were treated with 
genistein or herbimycin A, the expression of E2F-1 gene 
was much suppressed, while H-7 and A-3 showed no 
significant effect on the expression of E2F-1 gene (Fig. 
5B). 
All results shown above suggest hat the entry into S 
phase in mouse BALB/c 3T3 fibroblasts is regulated by 
cell adhesion to substratum through the activation of tyro- 
sine kinases other than growth factor receptor-tyrosine 
kinases. 
4. Discussion 
In the cultured fibroblasts, progression of G1 phase is 
critically regulated by growth factors and cell adhesion. 
Generally, in late G1 phase, especially at the period of 
G1/S transition, there is a restriction point or a commit- 
ment point. These points are reported to be located at 2 h 
or 3.5 h before or just before starting S phase [1-3]. They 
are taken as critical points to initiate a new division cycle, 
and serum is required up to these points for the cells to 
proceed into S phase [1-4]. In this experiment, we showed 
that the requirement for serum was during 0-8 h (mostly 
in early G1 phase (0-4 h)) after serum stimulation. On the 
other hand, the requirement for adhesion was clearly in 
late GI phase (8-14 h), especially at the period of G1/S 
transition. These results suggest hat cell adhesion to sub- 
stratum directly regulates the S phase entry at the period 
after the restriction point, which raises the possibility that 
cell adhesion activates its own signal transduction path- 
ways different from the growth factor-mediated signal 
transduction pathways for the G1/S phase transition. 
It has been reported that genistein and herbimycin A 
specifically inhibit the activities of protein tyrosine ki- 
nases. Genistein inhibits the tyrosine kinase activities of 
EGF receptor, pp60 Sr~, and pp110 gag-fes in vitro and also in 
vivo and does not inhibit the serine/threonine kinase 
activities of protein kinases A and C, phosphorylase ki- 
nase, 5'-nucleotidase, phosphodiesterase, and cdc2 kinase 
[22,27]. Herbimycin A inhibits tyrosine kinase activity of 
v-src in vitro and suppresses the transforming activity of 
tyrosine kinase oncogenes including src, yes, fps, ros, abl, 
and erbB [23]. However, the inhibitors also show some 
effects on the enzymes other than tyrosine-specific protein 
kinases. Genistein inhibits the activities of $6 kinase, DNA 
topoisomerases I and II, and phosphatidylinositol turnover. 
Herbimycin A also inhibits T-cell receptor-mediated phos- 
phoinositide hydrolysis [22,23]. In this paper, we showed 
that genistein and herbimycin A blocked the G1/S transi- 
tion of mouse fibroblasts. Although it is possible that the 
activity of the important enzymes other than tyrosine 
kinases are also suppressed by the inhibitors, our results 
strongly suggest hat the activation of tyrosine kinases is 
required for G I /S  transition. The reasons are as follows. 
(1) Genistein and herbimycin A inhibit the tyrosine kinase 
activities in completely different ways. Nevertheless, G I /S  
transition was blocked by both inhibitors. (2) Daidzein, 
whose structure is very close to that of genistein, did not 
block the G1/S transition. (3) Herbimycin A did not block 
the GI,/S transition when cells were treated together with 
a sulfhydryl compound, /3-mercaptoethanol, which is 
known as a compound which cancels the inhibitory effect 
of herbimycin A on tyrosine kinase activity. (4) Although 
genistein may inhibit topoisomerase II activity, the expres- 
sions of histone H2B, DHFR, and E2F-1 genes were also 
suppressed by genistein. (5) $6 kinase and phosphatidyl 
inositol turnover may also be inhibited by genistein, but 
these are activated immediately atearly phase of GI, not at 
the G I /S  transition. 
Our observations uggest hat cell adhesion plays a 
critical role in the G1/S phase transition through the 
activation of tyrosine kinases. One possible mechanism for 
this is in the signal transduction pathways of adhesion via 
adhesion plaques, where integrins are located and bind to 
extracellular matrix such as fibronectins and collagens. 
Several reports have indicated that phosphotyrosine- 
containing proteins are concentrated in adhesion plaques 
and that the binding of integrins to extracellular matrices 
can alter cellular tyrosine-phosphorylation patterns [28]. 
This is shown by the facts that focal adhesion kinase, 
which is localized in adhesion plaques, is tyrosine- 
phosphorylated by integrin-ligand interaction (caused by 
adhesion) and that the change in tyrosine-phosphorylation 
is correlated with an increase in its tyrosine kinase activity 
[12,13,28]. Additionally, several pieces of evidence sug- 
gest that src family tyrosine kinases are located in adhe- 
sion plaques and are involved in the signal transduction 
pathways from integrins [13-15]. The chemical signal 
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transduction from integrins through the tyrosine kinase 
activation of these molecules located in adhesion plaques 
may directly or indirectly regulate the activity of the 
molecules important for S phase entry. 
Another possible mechanism is that the cell shape and 
internal cellular architecture constructed by cell adhesion 
support he activation of some tyrosine kinases important 
for the G1/S transition. It is commonly accepted that cell 
shapes are important for cell growth and differentiation. 
Some observations suggest hat, in addition to chemical 
signaling, binding of integrins to extracellular molecules 
may regulate growth through some form of mechanical 
signaling [28]. It is reported that the binding of integrin to 
extracellular molecules is sufficient o induce the G0/G1 
transition. However, for S phase entry, the spreading of 
cells is required [29]. It is not yet clear what kind of 
tyrosine kinases require cell adhesion for their enzymatic 
activation. Cdk 2 kinase plays a critical role in S phase 
initiation function [30]. The activity of cdk2 kinase is 
regulated by its binding to cyclin E /A  and by the 
phosphorylation f its amino acid residues. Cdk 2 kinase is 
inactivated by phosphorylation f threonine 14 (Thr 14) 
and tyrosine 15 (Tyrl5) in G1 phase. At the G1/S transi- 
tion, cdk 2 kinase is activated by dephosphorylation f 
Thrl4 and Tyrl5 by cdc 25 phosphatase and also by 
phosphorylation f Thrl60 by CAK kinase [31-33]. As 
cdk 2 kinase is inactivated by the phosphorylation f its 
tyrosine residues (Tyrl5), it remains unclear whether or 
not activation of tyrosine kinases is positively required for 
initiation of S phase at the period of G1/S transition in 
respect o cdk 2 kinase activation. Further study of G1/S 
transition at the molecular level is needed to understand 
the precise regulatory mechanisms of cell adhesion in the 
G 1/S phase transition. 
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